| Popis: |
BACKGROUND The impact of remote monitoring (RM) in advanced heart failure cardiac implantable electronic device (CIED) patients during COVID-19 lockdown has not been established. OBJECTIVE RM can play crucial role in the follow-up of CIED implanted heart failure patients during COVID-19 pandemia. METHODS This single centre observational study was aimed to assess follow-up data of 61 remote monitored (RMG) vs. 71 conventional followed (CFG), symptomatic heart failure patients with implantable cardiac defibrillators (ICD) or cardiac resynchronization-therapy (CRT) pacemakers/defibrillators during 6 months of lockdown. The investigation analyzed worsening heart failure, arrhythmia, device related adverse evet rates (primary end point) and hospitalization rates for worsening heart failure (secondary end point). RESULTS Although, patients in the RMG had significantly more cardiovascular comorbidities and significantly worse functional class at baseline than CFG patients (NYHA class mean ± SD: [2,74 ± 0,44] vs. [2,34 ± 0,48]; P < .001), there was no difference in the composite end point of worsening heart failure, arrhythmia or device related adverse events. However, RMG patients had relative modest deterioration in heart failure functional class at in-office patient evaluations for worsening heart failure events (∆NYHA mean: 0,8 ; ∆NYHA mean: 1,5 ; P = .026). In addition, patients in RMG were significantly less hospitalized for worsening heart failure (0,0164 event/patient vs. 0,169 event/patient; P = .012). CONCLUSIONS : In this observational study remote monitored CIED implanted heart failure patients had significant benefit of lower hospitalization rate for worsening heart failure even on short term follow-up during lockdown. |
